BullFrog AI Holdings, Inc. develops AI and machine-learning technology for drug discovery and development, using platforms such as bfLEAP®, bfPREP™, and bfARENAS™ to analyze biomedical data, harmonize clinical information, and support pharmaceutical portfolio and trial-design decisions.
Recurring news themes include customer and partner activity with pharmaceutical and biotechnology organizations, research-institution collaborations, product launches for precision AI workflows, and presentations of platform-derived findings in oncology and other therapeutic areas. Company updates also cover balance-sheet actions, Nasdaq listing compliance, shareholder communications, and participation in life-sciences conferences such as AACR and ASCO GI.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.